Pathogenesis of HIV-associated cardiovascular complications.
Reviews and studies published before the introduction of highly active antiretroviral therapy (HAART) have tracked the incidence and course of HIV infection in relation to cardiac illness in both children and adults. The introduction of HAART regimens has significantly modified the course of HIV disease, with longer survival rates and improvement of life quality in HIV-infected people expected. However, early data raised concerns about HAART being associated with an increase in both peripheral and coronary arterial diseases. In this review we discuss HIV-associated cardiovascular complications focusing on pathogenetic mechanisms that could have a role in diagnosis, management, and therapy of these complications in the HAART era.
Barbaro
G
G
Department of Emergency Medicine, University La Sapienza, Rome, Italy. g.barbaro@tin.it
Fisher
S D
SD
Lipshultz
S E
SE
D017088:AIDS-Related Opportunistic Infections / Q000209:etiology / Q000473:pathology; D000328:Adult; D000818:Animals; D023241:Antiretroviral Therapy, Highly Active; D002311:Cardiomyopathy, Dilated / Q000453:epidemiology / Q000209:etiology / Q000473:pathology; D002648:Child; D003327:Coronary Disease / Q000453:epidemiology / Q000209:etiology / Q000473:pathology; D015658:HIV Infections / Q000188:drug therapy* / Q000635:transmission; D006801:Humans; D015994:Incidence; D008253:Macaca mulatta; D023421:Models, Animal; D016097:Simian Acquired Immunodeficiency Syndrome / Q000473:pathology